Literature DB >> 18267360

Synthesis and antimicrobial activity of beta-lactam-bile acid conjugates linked via triazole.

Namdev S Vatmurge1, Braja G Hazra, Vandana S Pore, Fazal Shirazi, Pradnya S Chavan, Mukund V Deshpande.   

Abstract

Synthesis of novel 1,2,3-triazole-linked beta-lactam-bile acid conjugates 17-24 using 1,3-dipolar cycloaddition reaction of azido beta-lactam and terminal alkyne of bile acids in the presence of Cu(I) catalyst (click chemistry) have been realized. These molecules were evaluated in vitro for their antifungal and antibacterial activities. Most of the compounds exhibited significant antifungal and moderate antibacterial activity against all the tested strains.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18267360     DOI: 10.1016/j.bmcl.2008.01.102

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  19 in total

1.  Design, synthesis, in vitro cytotoxic activity evaluation, and apoptosis-induction study of new 9(10H)-acridinone-1,2,3-triazoles.

Authors:  Maryam Mohammadi-Khanaposhtani; Maliheh Safavi; Reyhaneh Sabourian; Mohammad Mahdavi; Mahboobeh Pordeli; Mina Saeedi; Sussan Kabudanian Ardestani; Alireza Foroumadi; Abbas Shafiee; Tahmineh Akbarzadeh
Journal:  Mol Divers       Date:  2015-07-14       Impact factor: 2.943

2.  Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies.

Authors:  Mohammad Sadegh Asgari; Maryam Mohammadi-Khanaposhtani; Zeinab Sharafi; Mohammad Ali Faramarzi; Hossein Rastegar; Ensieh Nasli Esfahani; Fatemeh Bandarian; Parviz Ranjbar Rashidi; Rahmatollah Rahimi; Mahmood Biglar; Mohammad Mahdavi; Bagher Larijani
Journal:  Mol Divers       Date:  2020-03-18       Impact factor: 2.943

3.  Design, synthesis, anticancer activity and docking studies of theophylline containing 1,2,3-triazoles with variant amide derivatives.

Authors:  Radhakrishnam Raju Ruddarraju; Adharvana Chari Murugulla; Ravindar Kotla; Muni Chandra Babu Tirumalasetty; Rajendra Wudayagiri; Shobha Donthabakthuni; Ravichandar Maroju
Journal:  Medchemcomm       Date:  2016-10-28       Impact factor: 3.597

4.  3-(2,4-Dichloro-phen-oxy)-1-(4-meth-oxy-phen-yl)-4-(3-nitro-phen-yl)azetidin-2-one.

Authors:  Mehmet Akkurt; Sevim Türktekin; Aliasghar Jarrahpour; Seid Ali Torabi Badrabady; Orhan Büyükgüngör
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-12-18

5.  Advances in synthetic approach to and antifungal activity of triazoles.

Authors:  Kumari Shalini; Nitin Kumar; Sushma Drabu; Pramod Kumar Sharma
Journal:  Beilstein J Org Chem       Date:  2011-05-25       Impact factor: 2.883

6.  1-(4-Meth-oxy-phen-yl)-4-(3-nitro-phen-yl)-3-phen-oxy-azetidin-2-one.

Authors:  Zeliha Baktır; Mehmet Akkurt; Aliasghar Jarrahpour; Roghaye Heiran
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-01-29

7.  Synthesis and evaluation of some new aza-B-homocholestane derivatives as anticancer agents.

Authors:  Yanmin Huang; Jianguo Cui; Sijing Chen; Qifu Lin; Huacan Song; Chunfang Gan; Bin Su; Aimin Zhou
Journal:  Mar Drugs       Date:  2014-03-25       Impact factor: 5.118

Review 8.  The application of click chemistry in the synthesis of agents with anticancer activity.

Authors:  Nan Ma; Ying Wang; Bing-Xin Zhao; Wen-Cai Ye; Sheng Jiang
Journal:  Drug Des Devel Ther       Date:  2015-03-12       Impact factor: 4.162

9.  Synthesis and Antitumor Activity of 1-Substituted 1,2,3-Triazole-Mollugin Derivatives.

Authors:  Han Luo; Yong-Feng Lv; Hong Zhang; Jiang-Miao Hu; Hong-Mei Li; Shou-Jin Liu
Journal:  Molecules       Date:  2021-05-28       Impact factor: 4.411

10.  Discovery of novel 1,2,3-triazole derivatives as anticancer agents using QSAR and in silico structural modification.

Authors:  Veda Prachayasittikul; Ratchanok Pingaew; Nuttapat Anuwongcharoen; Apilak Worachartcheewan; Chanin Nantasenamat; Supaluk Prachayasittikul; Somsak Ruchirawat; Virapong Prachayasittikul
Journal:  Springerplus       Date:  2015-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.